Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CPT
NYSE:CPTResidential REITs

A Look At Camden Property Trust (CPT) Valuation As Class Action Settlement Reduces Legal Uncertainty

Camden Property Trust (CPT) has entered into a binding term sheet to settle a class action lawsuit, agreeing to contribute US$53 million to a settlement fund and to adopt specific business practice commitments, subject to court approval. See our latest analysis for Camden Property Trust. After this settlement announcement, Camden Property Trust’s recent share price momentum has been improving, with a 7.60% 1 month share price return. However, the year to date share price return is still...
NasdaqGS:FTDR
NasdaqGS:FTDRConsumer Services

Why Frontdoor (FTDR) Is Up 7.8% After Expanding Its SkySlope Real Estate Integration to 43 States

In April 2026, Frontdoor, Inc. announced that its American Home Shield brand is expanding a six-year partnership with technology provider SkySlope from 4 to 43 states, streamlining the home warranty application process for nearly 175,000 real estate agents and brokers through a single, automated workflow. This move materially strengthens Frontdoor’s integration into real estate transaction workflows, potentially making its home warranty products more embedded and convenient for agents and...
TSXV:QZM
TSXV:QZMMetals and Mining

Bri-Chem Leads 3 Promising Penny Stocks On The TSX

As the Canadian market navigates a landscape of economic uncertainty and fluctuating energy supplies, investors are cautiously optimistic about opportunities in smaller sectors. Despite their vintage-sounding name, penny stocks continue to offer intriguing prospects for those willing to explore beyond the mainstream indices. By focusing on strong financial foundations and potential for growth, these stocks can provide investors with a chance to uncover hidden value in promising companies.
ENXTPA:MC
ENXTPA:MCLuxury

LVMH Lawsuit Puts Stella McCartney Conduct And Governance Under Spotlight

A newly filed US federal lawsuit targets Stella McCartney, an LVMH owned brand, alleging whistleblower retaliation, unequal pay, and anti competitive pricing practices. The complaint also refers to broader concerns around LVMH Moët Hennessy Louis Vuitton Société Européenne, ticker ENXTPA:MC, including references to recent European antitrust scrutiny. The case raises questions about workplace practices and competition issues that could carry legal and reputational implications for the wider...
TSX:GOLD
TSX:GOLDMetals and Mining

Assessing GoldMining (TSX:GOLD) Valuation After Wider First Quarter Loss And Mixed Share Performance

Earnings-triggered attention on GoldMining GoldMining (TSX:GOLD) is drawing fresh attention after reporting first quarter results to February 28, 2026, with a net loss of CA$6.64 million and basic loss per share of CA$0.03 from continuing operations. See our latest analysis for GoldMining. Following the wider first quarter loss, GoldMining's recent 22.82% 1 month share price return and 7.65% year to date share price return contrast with a 17.19% 3 month share price decline and a 57.76% 1 year...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Assessing Open Text (NasdaqGS:OTEX) Valuation After European Data Sovereignty Push And Leadership Changes

Open Text (NasdaqGS:OTEX) just highlighted its European focus, rolling out data and AI offerings on the AWS European Sovereign Cloud and teaming up with S3NS in France, while refreshing client-facing leadership roles. See our latest analysis for Open Text. These European cloud and data-sovereignty moves arrive after a 7 day share price return of 5.89% and a 30 day gain of 3.50%. However, they sit against a 26.40% year to date decline and a 5 year total shareholder return of 43.47% in the red,...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Is Septerna (SEPN) Quietly Redefining Its GPCR Strategy With This First-in-Human SEP-479 Trial?

Septerna, Inc. recently began dosing healthy volunteers in a randomized, placebo-controlled Phase 1 trial of SEP-479, an oral PTH1R agonist for hypoparathyroidism, using single-ascending and multiple-ascending dose designs to assess safety, tolerability, pharmacokinetics and pharmacodynamics. This first-in-human study, which could enroll up to 150 participants and tracks biomarkers such as endogenous PTH and serum calcium, marks a key progression of Septerna’s GPCR-targeted pipeline into...
NYSE:CWT
NYSE:CWTWater Utilities

Assessing California Water Service Group (NYSE:CWT) Valuation After Recent Share Price Momentum

California Water Service Group (CWT) has attracted fresh attention after recent share price moves, with the stock showing gains over the past week, month, and past 3 months relative to its last close of $46.85. See our latest analysis for California Water Service Group. That recent 4.2% 1 day share price return and 6.7% 30 day share price return sit against a 1 year total shareholder return decline of 5.2%. This suggests short term momentum is improving while longer term returns remain under...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Vertex And Two More Stocks Possibly Priced Below Their Estimated Worth

Over the last 7 days, the United States market has risen by 3.6%, and over the past year, it has seen a remarkable increase of 39%, with earnings forecasted to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer opportunities for investors looking to capitalize on discrepancies between current prices and estimated worth.
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness

Context for Vertex Pharmaceuticals after recent share performance Vertex Pharmaceuticals (VRTX) has recently seen its share price under pressure, with a 3.3% decline over the past month and an 8.0% negative total return over the past year. This performance has prompted closer attention from investors. See our latest analysis for Vertex Pharmaceuticals. With the share price at US$439.18 and a 1 year total shareholder return of 8.0% in the red, but a 5 year total shareholder return of 102.4%,...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group’s Homes.com Push Reframing Its Core Strategy and Risk Profile for Investors (CSGP)?

In recent weeks, CoStar Group’s Homes.com platform released a March report spotlighting the priciest publicly marketed home sales across major U.S. metros, led by a US$170 million Miami estate, with Los Angeles and New York City also registering ultra-luxury transactions. At the same time, hedge fund Third Point publicly exited its CoStar position after criticizing ongoing investment in Homes.com, highlighting growing debate over how the residential push fits within CoStar’s broader business...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Is Marriott (MAR) Using Fashion-Led Luxury To Redefine Its Brand Moat And Pricing Power?

Marriott International’s Luxury Collection is partnering with designer Margherita Maccapani Missoni on an immersive Milan Design Week pop-up and capsule fashion collection at Casa Brera, while also advancing its Autograph Collection footprint with the NUMAJ hotel in Saudi Arabia’s AlUla and opening the Noormahal Palace Hotel in Karnal, India. Together, these moves highlight Marriott’s push to deepen its luxury positioning by blending high-end hospitality with fashion-led experiences and...
BIT:IVG
BIT:IVGMachinery

Assessing Iveco Group (BIT:IVG) Valuation As A Special Cash Dividend Draws Investor Focus

Special cash dividend puts Iveco Group (BIT:IVG) in focus Iveco Group (BIT:IVG) is drawing attention after announcing a special cash dividend of €5.8216 per share, with the ex-dividend date set for April 20, 2026, a development many income-focused investors are watching closely. See our latest analysis for Iveco Group. Despite the special dividend news, Iveco Group’s share price has declined around 26% to €13.99 over the past month. However, its 1 year total shareholder return of 51.21% and 3...
NYSE:DOUG
NYSE:DOUGReal Estate

3 Promising Penny Stocks With Market Caps Over $20M

Over the last 7 days, the United States market has risen 3.6%, and over the past year, it has climbed 39%, with earnings expected to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for investors seeking growth at lower price points. By focusing on those with strong balance sheets and solid fundamentals, these stocks can present an underappreciated chance for stability and potential upside in today's market conditions.
NYSE:ZWS
NYSE:ZWSBuilding

A Look At Zurn Elkay Water Solutions (ZWS) Valuation After Recent Share Price And Narrative Shifts

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has attracted investor attention following a period in which the stock posted a modest one-day move, weaker performance over the past week, and positive returns over the past month and past three months. See our latest analysis for Zurn Elkay Water Solutions. At a share price of $47.78, Zurn Elkay Water Solutions has recently paired a weaker 7 day share price return with a stronger 1 month share price return, while its 1 year total...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)?

10x Genomics has launched Atera, an in situ spatial biology platform offering whole-transcriptome, single-cell–sensitivity analysis at scale across fresh-frozen and FFPE tissues, with pre-orders open and shipments targeted for the second half of 2026. Early Atera data from leading groups like the June Lab and the German Cancer Research Center suggest the platform can reveal previously hidden tumor–immune interactions that may reshape research and drug discovery approaches. We’ll now examine...
NYSE:UAA
NYSE:UAALuxury

A Look At Under Armour’s (UAA) Valuation After Its New Youth Sports Partnership With Unrivaled Sports And DICK'S

Under Armour (UAA) is back in the spotlight after Unrivaled Sports announced new partnerships with the brand and DICK'S Sporting Goods, focused on youth sports programming nationwide and exclusive apparel roles at marquee events. See our latest analysis for Under Armour. Investors have seen momentum build recently, with a 7 day share price return of 7.65% and a 30 day share price return of 12.99%. At the same time, the 1 year total shareholder return of 15.16% contrasts with a 5 year total...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Why Affirm Holdings (AFRM) Is Up 29.0% After Morgan Stanley Names It a Top Pick

Morgan Stanley recently elevated Affirm Holdings to its Top Pick list, arguing that concerns around private credit are too pessimistic and pointing to upcoming company updates on gross merchandise volume, margins, and long-term earnings targets at its May Investor Forum as important reference points. An interesting angle is Morgan Stanley’s expectation that Affirm will outline a fiscal 2028 GAAP EPS range that the bank views as conservative, potentially reframing how investors think about...
NasdaqGS:RRBI
NasdaqGS:RRBIBanks

Discovering 3 Undiscovered Gems in the US Market

The United States market has experienced a notable upswing, climbing 3.6% over the last week and an impressive 39% over the past year, with earnings projected to grow by 16% annually. In such a dynamic environment, identifying stocks that are not only poised for growth but also remain under the radar can offer unique opportunities for investors seeking to capitalize on market momentum while discovering potential value.
OM:SKA B
OM:SKA BConstruction

Skanska (OM:SKA B) Valuation Check After Strong Multi Year Shareholder Returns

Skanska stock triggered overview Skanska (OM:SKA B) has come back into focus for investors after recent share price moves, with the stock showing mixed short term returns and a 1 year and 3 year total return profile. See our latest analysis for Skanska. At a share price of SEK258.1, Skanska has recently seen a 6.39% 1 month share price return, while its 1 year total shareholder return of 31.05% and 3 year total shareholder return of 81.66% point to momentum built over a longer horizon. If you...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

Assessing East West Bancorp (EWBC) Valuation After Its Recent Momentum-Fueled Share Price Gains

What recent performance says about East West Bancorp East West Bancorp (EWBC) has drawn attention after a strong month, with the stock showing a 15% return and a gain of about 6% over the past 3 months. This recent performance has prompted some investors to reassess its valuation. See our latest analysis for East West Bancorp. Putting that move in context, the 15.0% 1 month share price return sits alongside a 3.5% year to date share price return and a 60.2% 1 year total shareholder return...
TSX:AG
TSX:AGMetals and Mining

A Look At First Majestic Silver’s Valuation After A Strong Run In The Share Price

What Recent Performance Tells You About First Majestic Silver First Majestic Silver (TSX:AG) has drawn fresh attention after a strong month, with the share price up about 17%, while the past 3 months show a 5% decline and a 1-year total return above 200%. See our latest analysis for First Majestic Silver. At the current share price of CA$29.44, First Majestic Silver has recently shown strong short term momentum with a 1 month share price return of 17.48%, while the 1 year total shareholder...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Did Citi’s Downgrade and New CCO Hire Just Reframe Insulet’s (PODD) Competitive Playbook?

Recently, Citigroup cut its rating on Insulet Corporation to Neutral, citing rising competition in the patch insulin pump market and the potential impact of rival devices expected to arrive in 2027. At the same time, Insulet appointed Mike Panos as Executive Vice President and Chief Commercial Officer, highlighting the company’s focus on strengthening global commercialization of its Omnipod platform despite a more crowded competitive landscape. Next, we’ll examine how Citigroup’s downgrade,...